Credence Research: Industry Analysis Report for Companion Diagnostics Market 2017

The market was valued at USD 3,717.2 Mn in 2015, and is expected to reach USD 14,453.3 Mn by 2023, expanding at a CAGR of 18.5% from 2016 to 2023.

In the latest report published by Credence Research, Inc. “Companion Diagnostics Market – (Technology Type – Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization Test, Gene Sequencing and Others; Indication Type – Oncology, Cardiovascular Diseases, Infectious Diseases and Autoimmune Diseases): Growth, Future Prospects and Competitive Analysis, 2016-2023,” the market was valued at USD 3,717.2 Mn in 2015, and is expected to reach USD 14,453.3 Mn by 2023, expanding at a CAGR of 18.5% from 2016 to 2023.
Market Insights
Companion diagnostic tests are used to identify suitable patients for administering specific drugs and monitoring the prognosis of drug effects on the disease. This concept of combining a drug with a diagnostic test is known as predictive medicine or personalized medicine. A companion diagnostic test has the ability to predict the risks of the disease and monitor its therapeutic response. On the basis of technology the companion diagnostics market has been segmented into polymerase chain reaction, immunohistochemistry, In-situ hybridization test, gene sequencing and others. The others segment includes tests such as monoclonal antibodies test and cellular immune testing.
Browse the full report Companion Diagnostics: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/companion-diagnostics-market
The polymerase chain reaction technique is the largest segment in the global companion diagnostics market. On the basis of indication the global companion diagnostics market has been segmented as oncology, cardiovascular diseases, virology and autoimmune diseases. The oncology segment has been further segmented on the basis of various cancers such as breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma and other cancer. The oncology segment held the largest market in the global companion diagnostics by indication and is expected to be the highest grossing segment through the forecast period. The major factors driving the oncology segment include development of majority of companion diagnostics for detection of various cancer biomarkers.
The geographical segmentation of the global companion diagnostics market comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In base year 2015, North America accounted for the largest market in the global companion diagnostics. In North America, the US represented the largest market for companion diagnostic tests. Asia Pacific is expected to grow at a highest rate during the forecast period due increased adoption, technological advancements, and demand for personalized medicine. the increase in the prevalence of cancer and associated disorders, the increase in healthcare expenditure, and the increase in the level of awareness among the population. Thus, the APAC region is expected to adopt companion diagnostics tests at a rapid rate during the forecast period.
The key players operating in the global companion diagnostics market include Abbott Laboratories Inc., Agilent Technologies Inc., bioMerieux SA, Qiagen N.V., Roche Holdings AG, Thermo Fisher Scientific Inc. The other notable players include Ventana Medical Systems, Myriad Genetics, Leica Microsystems and others.
Browse the full report Companion Diagnostics: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/companion-diagnostics-market
ToC:
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Global Companion Diagnostics Market Portaiture
2.2 Global Companion Diagnostics Market, by Indication, 2015 (USD Mn)
2.3 Global Companion Diagnostics Market, by Technology, 2015 (USD Mn)
2.4 Companion Diagnostics Market Share, by Geography, 2015 (Value %)
Chapter 3 Companion Diagnostics : Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Epidemiology of Thyroid Disorders
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increased Focus on Cost Cutting in Drug Discovery and Development
3.3.1.2 Increased Popularity of Personalized Medicines
3.3.1.3 Rapid Advancements in Science and Technology
3.3.1.4 Increase in Prevalence of Cancer and Other Disorders
3.3.2 Challenges
3.3.2.1 High Cost Involved in Companion Diagnostics Development
3.3.1.2 Stringent Regulations
3.3.1.3 Need for Multidisciplinary Approach to Develop Efficient Companion Diagnostics
3.3.3 Opportunities…
Request Sample: http://www.credenceresearch.com/sample-request/58078

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com


Contact Details

Company Name: Credence Research
Issued By: Robson Tolson
Phone: 18003618290
Address: 105 N 1st ST #429, SAN JOSE, CA 95103, United States
City: SANJOSE
State: CALIFORNIA
Zip: 95103
Country: United States
Website: Visit the website

Keywords : Companion Diagnostics Market,

by Robson Tolson (few months ago!)

Latest Press Releases

Copywriter Sanchita Agarwal publishes a Mystery Book - The Mystic Girls

Ex-World Bank Consultant Dr Tikam Jain publishes his Memoir!

Contact Cartoozo for the Most Affordable Web Development in the UK

Dr. Song Offers Advanced 3D Prostate Targeted Treatments from China

Sjitindia.com Indian Cam Girls Make Live Webcam Chat a Festival of Amativeness Every Day

Global Enzyme-Linked Immunosorbent Assay Market Report 2017(Sandwich/Indirect/Competitive ELI..

Best Online Pharmacies

Conditioner Market in Saudi Arabia

Look Your Professional Best with PowerPoint Presentation Design

The Insight Partners: Global Busway Market is projected to reach US$ 10.81 billion by 2025

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.